The results reinforce the idea that targeting protein synthesis with small molecules in patients carrying C9ORF72 mutations may result in improved cognitive capacity and reinforce the idea that targeting protein synthesis with small molecules in patients carrying ALS may result in improved cognitive capacity.
Chronic administration of low doses of DHQ exerted neuroprotective effects in both AD and ALS genetic models, which partially translated to reduced manifestations of these diseases.
E. Lysikova, K. Sitdikova, Aigerim Makhambetova et al.· Cells· 1 citation
The results indicate the cognitive improvement and neuroprotective effects of DMF in Aβ1-42 CE model by modulating the necroptosis signalling and suggest that the selective targeting of necroptosis process may open new treatment avenues for AD.
Sandeep Guin, Aditi Jangli, Manoj P. Dandekar· International Immunopharmaco...· 0 citations
Investigating the potential of the skin allergen Isoeugenol to activate Nrf2 and reverse selected AD hallmarks, both in vitro and in vivo, in AD‐specific models reinforces Isoeugenol as a pleiotropic molecule, with great potential for AD treatment.
Ana Silva, Sónia Silva, Jéssica Macedo et al.· The FASEB Journal· 0 citations
Objective T cells are increased in the brain in Alzheimer’s disease (AD) and primary tauopathies where they correlate with tau pathology. In mouse models, T cells exacerbate tau-related neuroinflammation and neurodegeneration, and depletion of T cells is neuroprotective. Here, we investigate whether the multiple sclero...
M. Rudman, Alexandra Litvinchuk, Cathryn Smith et al.· bioRxiv· 0 citations
Investigation of the neuroprotective potential and associated signaling alterations of erinacine C using APP/PS1 transgenic mice and Aβ25-35-induced PC12 cells suggest that EC may mitigate cognitive impairment and neurodegeneration in parallel with alterations in the Akt/GSK3β/tau/caspase-3 signaling response.
Overall, the findings indicate limited efficacy of ATO in this αSyn-driven setting and support further comparative evaluation of individual statins across complementary PD models.
Li-Jian Wei, Jun-Kai Hua, Shu Tang et al.· Neurotoxicity research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.